A cross-sectional study of the clinical characteristics of hospitalized children with community-acquired pneumonia in eight eastern cities in China

Table 4 Treatment modalities in children hospitalised with pneumonia in the sampled hospitals

Medications	TCM hospitals		WM hospitals		χ²	P value
Medications	Number (n = 598)	%	Number (n = 700)	%	χ²	P value
Antibiotics
IV	595	99.5	699	99.9	-	0.34
Macrolide	383	64.0	357	51.0	22.40	<0.01
Third generation cephalosporin	186	31.1	390	55.7	79.13	<0.01
Second generation cephalosporin	114	19.1	186	26.6	10.23	0.01
First generation cephalosporin	98	16.4	89	12.7	3.53	0.06
β-lactamase inhibitor	73	12.2	101	14.4	1.37	0.24
Oral	65	10.9	243	34.7	101.32	<0.01
Inhalation^a	8^a	1.3	0	0.0	-	<0.01
Antiviral drugs
IV	10	1.7	77	11.0	44.87	<0.01
Inhalation	41	6.9	43	6.1	0.27	0.60
β2 agonist
Oral	205	34.3	216	30.9	1.73	0.19
Inhalation	342	57.2	205	29.3	102.99	<0.01
Steroids
IV	61	10.2	39	5.6	9.72	0.02
Inhalation	188	31.4	129	18.4	29.57	<0.01
TCM treatment
Chinese herbal extract injection	491	82.1	212	30.3	348.83	<0.01
Chinese patent drugs	239	40.0	297	42.2	0.81	0.37
Decoction	312	52.2	16	2.3	425.03	<0.01
External methods	320	53.5	179	25.6	106.39	<0.01

ISSN: 2662-7671